- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01683903
Comparison of Cardiac Rehabilitation Benefits Between Coronary and Non-coronary Patients Through a 24 Months Follow-up After Myocardial Infarction: the "INCARD" Study (INCARD)
Comparison of Cardiac Rehabilitation Benefits Between Coronary and Non-coronary Patients Through a 24 Months Follow-up : the "INCARD" Study
Descripción general del estudio
Estado
Condiciones
Descripción detallada
We will undertake a prospective follow-up study of 150 rehabilitated patients with heart failure (75 C; 75 NC). The main objective will be to compare the benefits of rehabilitation between coronary and non-coronary patients based on functional improvement i.e. improvements of VO2max, LVEF (ultrasound method and/or isotopic), 6-min walk test, Minnesota index of quality of life. In addition, clinical outcomes (HR, SBP, DBP, BMI) and paraclinical data (creatinine clearance) will be measured as patients' standard clinical follow-up .
Clinical data of the patients admitted to the cardiac rehabilitation, including heart failure patients (LVEF <40), will be recorded after collection of their signed informed consent agreement. Patients will be addressed from heart failure intensive care units for coronary (USIC) or acute cardiac services to the rehabilitation department. Patients will be admitted in the rehabilitation department when there are clinically stable (at least three weeks after the acute episode). Etiology of the heart failure will be assessed and patients stratified as C or NC patients.
Expected Results We will estimate the mean duration of inpatient rehabilitation (H period). Then, we will follow patients' cardiac evaluation parameters recorded from an outpatient follow-up, first 3 months after inclusion and then every 6 months over the 24 months of outpatient follow-up.
These data will allow for comparison of the benefits of rehabilitation between coronary (C) and non-coronary (NC) patients for each evaluation time point and will give information on the clinical improvement of each group of patients.
Tipo de estudio
Inscripción (Anticipado)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Corbeil, Francia, 91100
- Reclutamiento
- Centre Hospitalien Sud Francilien
-
Contacto:
- Francois Koukoui, MD
- Número de teléfono: 00(33)161698086
- Correo electrónico: francois.koukoui@ch-sud-francilien.fr
-
Investigador principal:
- Francois Koukoui, MD
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Age over 18 years old,
- Signed informed consent,
- Patients with left ventricular ejection fraction below 40 %,
- Stable for over 3 weeks,
- Known etiology,
- Able to do the performance test on treadmil or bicycle in order to have rehabilitation.
- No clinical avoidance reasons.
- Patient with health care registration.
- Agreement from the general practictioner and from the cardiologist that follows the patient.
Exclusion Criteria:
- Age below 18 years old,
- Unstable heart failure,
- Unable to do a performance test as indicated above,
- Patients not able to understand clinical counseling.
- Patient under tutella.
- Pregnancy.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
---|
Non coronary patients (NC)
Patient with myocardial infarction with non-coronary (NC) etiology
|
Coronary patients (C)
Patients with myocardial infarction due to coronary disease
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Change in VO2max every 6 months over the 24 months
Periodo de tiempo: every 6 months over the 24 months of outpatient follow-up
|
VO2max (L)
|
every 6 months over the 24 months of outpatient follow-up
|
Change in Left ventricular ejection fraction every 6 months over the 24 months of outpatient follow-up
Periodo de tiempo: every 6 months over the 24 months of outpatient follow-up
|
Left ventricular ejection fraction (ultrasound method and/or isotopic) in %
|
every 6 months over the 24 months of outpatient follow-up
|
Change on 6-min walk test every 6 months over the 24 months
Periodo de tiempo: every 6 months over the 24 months of outpatient follow-up
|
6-min walk test (m)
|
every 6 months over the 24 months of outpatient follow-up
|
Change on Minnesota index of quality of life every 6 months over the 24 months
Periodo de tiempo: every 6 months over the 24 months of outpatient follow-up
|
Minnesota index of quality of life.
|
every 6 months over the 24 months of outpatient follow-up
|
Change on heart rate every 6 months over the 24 months
Periodo de tiempo: every 6 months over the 24 months of outpatient follow-up
|
Heart rate (bpm)
|
every 6 months over the 24 months of outpatient follow-up
|
Change on systolic blood pressure every 6 months over the 24 months
Periodo de tiempo: every 6 months over the 24 months of outpatient follow-up
|
systolic blood pressure (mmHg)
|
every 6 months over the 24 months of outpatient follow-up
|
Change on diastolic blood pressure every 6 months over the 24 months
Periodo de tiempo: every 6 months over the 24 months of outpatient follow-up
|
diastolic blood pressure (mmHg)
|
every 6 months over the 24 months of outpatient follow-up
|
Change on body mass index every 6 months over the 24 months
Periodo de tiempo: every 6 months over the 24 months of outpatient follow-up
|
Measurement of weight and height, calculation of body mass index (kg/m2)
|
every 6 months over the 24 months of outpatient follow-up
|
Change on creatine clearance every 6 months over the 24 months
Periodo de tiempo: every 6 months over the 24 months of outpatient follow-up
|
creatine clearance (ml/min)
|
every 6 months over the 24 months of outpatient follow-up
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Publicaciones Generales
- Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008 Oct;29(19):2388-442. doi: 10.1093/eurheartj/ehn309. Epub 2008 Sep 17. No abstract available. Erratum In: Eur Heart J. 2010 Apr;12(4):416. Dosage error in article text. Eur Heart J. 2010 Mar;31(5):624. Dosage error in article text.
- Koukoui F, Desmoulin F, Lairy G, Bleinc D, Boursiquot L, Galinier M, Smih F, Rouet P. Benefits of cardiac rehabilitation in heart failure patients according to etiology: INCARD French study. Medicine (Baltimore). 2015 Feb;94(7):e544. doi: 10.1097/MD.0000000000000544.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- INCARD
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Insuficiencia cardiaca
-
Region SkaneInscripción por invitaciónInsuficiencia cardíaca New York Heart Association (NYHA) Clase II | Insuficiencia cardíaca New York Heart Association (NYHA) Clase IIISuecia
-
Medical University of BialystokInstitute of Cardiology, Warsaw, Poland; Medical University of Lodz; Poznan University... y otros colaboradoresAún no reclutandoInsuficiencia Cardíaca Sistólica | Insuficiencia cardíaca con fracción de eyección reducida | Insuficiencia cardíaca Clase IV de la New York Heart Association | Insuficiencia cardíaca Clase III de la New York Heart AssociationPolonia
-
Novartis PharmaceuticalsTerminadoPacientes que completaron con éxito el período de tratamiento de 12 meses del estudio principal (receptores de Novo Heart) que estaban interesados en recibir tratamiento con EC-MPS
-
University of WashingtonAmerican Heart AssociationTerminadoInsuficiencia cardíaca, congestiva | Alteración mitocondrial | Insuficiencia cardíaca Clase IV de la New York Heart AssociationEstados Unidos